Search For "hyderabad based bharat biotech"
Japan approves COVAXIN booster dose for travellers: Bharat Biotech
Updated : 3 years, 10 months ago IST
Hyderabad [Telangana], August 5 (ANI): Hyderabad-based Bharat Biotech on Friday announced that Japan has approved the COVAXIN booster dose for travellers.
Read More
Covaxin booster dose increases immune response by 40 times, gives long-ter
Updated : 3 years, 10 months ago IST
Hyderabad (Telangana) [India], July 20 (ANI): Hyderabad-based Bharat Biotech on Wednesday announced that the administration of the third dose of its COVID-19 vaccine Covaxin (BBV152) after six months of two-dose vaccination dramatically increased neutralizing antibody responses against both
Read More
No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO susp
Updated : 4 years, 2 months ago IST
Hyderabad (Telangana)[India], April 3 (ANI): Hyderabad-based Bharat Biotech on Sunday issued a clarification that there is "no impact on efficacy and safety of the COVID-19 vaccine COVAXIN" after the World Health Organisation suspended it from its Covax facility.
Read More
Covaxin to be evaluated as COVID-19 vaccine candidate in US: Bharat Biotec
Updated : 4 years, 3 months ago IST
Hyderabad (Telangana) [India], February 19 (ANI): Hyderabad-based Bharat Biotech on Saturday said its COVID-19 vaccine Covaxin will be evaluated as a vaccine candidate for the disease in the United States.
Read More
Covaxin can neutralise Delta, Omicron variants of coronavirus: Bharat Biot
Updated : 4 years, 4 months ago IST
New Delhi [India], January 12 (ANI): Hyderabad-based Bharat Biotech on Wednesday claimed that its COVID vaccine Covaxin can neutralise both Delta and Omicron variants of coronavirus.
Read More
Bharat Biotech seeks DCGI's approval for its intranasal COVID-19 booster d
Updated : 4 years, 5 months ago IST
New Delhi [India], December 20 (ANI): As India is witnessing a surge in cases of "highly transmissible" Omicron variant, Hyderabad-based Bharat Biotech has submitted the phase 3 clinical trial application to the Drugs Controller General of India (DCGI) to get approval for the booster dose
Read More
Lancet Infectious Diseases study compare well with phase 3 clinical trials
Updated : 4 years, 6 months ago IST
New Delhi [India], November 25 (ANI): Commenting on the study of the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obt
Read More
Bharat Biotech's Covaxin phase 3 data shows 77.8 pc efficacy against COVID
Updated : 4 years, 6 months ago IST
Hyderabad (Telangana) [India], November 12 (ANI): Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech's Covaxin.
Read More
Good news for Indian travellers, says AIIMS Dr Sanjay Rai on WHO's approva
Updated : 4 years, 7 months ago IST
New Delhi [India], November 3 (ANI): The Professor of Community Medicine at AIIMS, Dr Sanjay Rai said on Wednesday that the World Health Organisation's (WHO) emergency use nod to Hyderabad based Bharat Biotech's Covid-19 vaccine, Covaxin is good news for Indians especially those vaccinates I
Read More
WHO chief 'glad' to see Covaxin get WHO approval for emergency use
Updated : 4 years, 7 months ago IST
Geneva [Switzerland], November 3 (ANI): Director-General of the World Health Organisation Tedros Adhanom Ghebreyesus on Wednesday said that he was glad to see Hyderabad-based Bharat Biotech's COVID-19 vaccine, Covaxin, get WHO approval for Emergency Use Listing (EUL).
Read More
WHO's Soumya Swaminathan congratulates India for Covaxin emergency nod
Updated : 4 years, 7 months ago IST
Geneva [Switzerland], November 3 (ANI): WHO Chief Scientist Soumya Swaminathan on Wednesday congratulated India after the World Health Organisation (WHO) granted approval for Emergency Use Listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine, Covaxin.
Read More
Jaishankar welcomes WHO's decision to grant Emergency Use Listing to Covax
Updated : 4 years, 7 months ago IST
New Delhi [India], November 3 (ANI): External Affairs Minister Dr S Jaishankar on Wednesday welcomed the World Health Organisation (WHO)'s decision to grant approval for Emergency Use Listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine, Covaxin.
Read More